BIRC5 as a Cancer Biomarker
Author Information
Author(s): Li Guoyu, Wang Yanghao, Wang Weizhou, Lv Guodong, Li Xiang, Wang Jingying, Liu Xiuyu, Yuan Daolang, Deng Shoujun, You Dingyun
Primary Institution: Kunming Medical University
Hypothesis
This study investigates the expression of BIRC5 across various cancer types and its significance as a diagnostic and prognostic biomarker.
Conclusion
BIRC5 is significantly overexpressed in multiple cancers, particularly lung adenocarcinoma, and is associated with poor prognosis and tumor progression.
Supporting Evidence
- BIRC5 was significantly overexpressed in tumor tissues across 33 cancer types.
- High BIRC5 expression was associated with poor prognosis in lung adenocarcinoma and kidney renal clear cell carcinoma.
- ROC analysis showed that BIRC5 exhibited strong diagnostic potential with AUC values greater than 0.9 in several cancers.
Takeaway
BIRC5 is a protein that helps cancer cells grow and survive, and measuring its levels can help doctors understand how serious a cancer is.
Methodology
The study analyzed RNA-seq data from TCGA and protein expression data from the Human Protein Atlas, comparing expression levels between tumor and normal tissues and evaluating correlations with molecular and immune subtypes.
Potential Biases
Potential biases may arise from the use of publicly available datasets and the inherent limitations of bioinformatics analyses.
Limitations
The study primarily relies on bioinformatics data and may not account for all biological variations in cancer.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI: 2.45–8.86
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website